Secretary Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to ...

Global vaccine stocks in focus as the U.S. government plans to phase out investment for mRNA vaccine development activities.

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

Bob Kennedy announced yesterday that the government’s emergency preparedness agency will no longer fund work on the miraculous messenger RNA vaccines, delivering a crippling blow to the country’s ...

RFK Jr. announced that the U.S. government’s emergency preparedness agency will no longer fund work on mRNA vaccines ...

Health secretary Robert F. Kennedy Jr. last night announced that the government’s emergency preparedness agency, BARDA, will ...

(Reuters) -Novavax beat Wall Street expectations for second-quarter revenue on Wednesday, helped by a $175 million milestone ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

U.S. Health Secretary Robert F. Kennedy Jr. has pulled $500 million in funding from mRNA vaccine research, according to the Department of Health and Human Services. “… The data ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.